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News
SciQuest.com Announces Opening of UK O￿ ce
Leading global e-marketplace for scienti￿ c indus-
try also announces strategic purchasing agree-
ment with Dow and Max-Planck-Institute:
opening of Paris and Walldorf, Germany, o￿ ces
Research Triangle Park, NC and Munich, Germany, 10 April
2000 SciQuest.com (NASDAQ: SQST), a leading business-
to-business e-marketplace for products used by pharma-
ceutical, chemical, biotechnology, industrial and educa-
tional organizations, today announced the opening of a
local o￿ ce to serve the UK scienti® c products market-
place and to initiate the hiring of British senior sta￿ . The
announcement was among several issued by SciQuest.
com at the Analytica Conference for Analysis, Biotech-
nology, Diagnostics and Laboratory Technology in Mu-
nich, Germany.
Established in 1995, SciQuest.com currently o￿ ers re-
searchers and procurement sta￿ the ability to source and
purchase approximately one million laboratory products
from more than 600 suppliers around the world. In North
America, SciQuest.com has used its extensive industry
experience to design a marketplace that streamlines the
traditionally ine￿ cient scienti® c products supply chain.
The company’s marketplace solutions allow buyers of
scienti® c products to cross-search content and purchase
products from multiple suppliers with a single order. The
company’s e-marketplace is distributor-neutral and can
be customized and seamlessly integrated with its custo-
mers’ enterprise systems, including SAP/R3.
SciQuest.com’s UK o￿ ce is to be co-located with the
established o￿ ces of EMAX Solutions, a SciQuest.com
company, at The Nova Building Herschel Street, Slough,
Berkshire SL1 1XS. In March, SciQuest.com completed
the acquisition of US-based EMAX, for the purpose of
creating an integrated e-business solution that manages
the entire lifecycle of scienti® c laboratory products, from
selection and procurement through ownership, use and
disposal.
`Expanding strategically into key European markets is an
important component of the SciQuest.com growth strat-
egy, since most of our established supplier companies and
customer research organizations are global,’ said Scott
Andrews, SciQuest.com co-founder and CEO. `Our sol-
ution streamlines the entire supply chain, allowing
scientists to reduce the amount of time spent in supply
procurement, while increasing the amount of time avail-
able for research and discovery. As the ® rst-mover in the
US with this model, we view today’s announcement as
a￿ rming our commitment to be the leading e-market-
place for the global science industry in the United
Kingdom and worldwide.’
Other News from SciQuest.com
Other news released today in Munich by SciQuest.com
includes:
. The launch of pilot purchasing programs at two
preeminent European research customers, The
Dow Chemical Company and the Max-Planck-
Institute. SciQuest.com will expand its strategic
North American e-commerce agreement for pur-
chase of scienti® c products and supplies to Dow
sites in Europe. SciQuest.com also will serve as the
strategic e-marketplace to conduct pilot testing for
designated scienti® c products purchases for The
Max-Planck-Institute of Molecular Cell Biology
and Genetics in Germany, integrating with MPI’s
existing SAP/R3 enterprise systems.
. The appointment of Dr Hans Peter Fatscher as
business development manager for Germany. Dr
Fatscher holds a PhD from the University of
Heidelberg’s Institute of Molecular Genetics and
brings more than 12 years of sales and management
experience for leading European pharmaceutical
and biotechnology companies to his new position
with SciQuest.com.
. The opening of additional SciQuest.com o￿ ces in
Paris and Walldorf, Germany. SciQuest.com’s
French o￿ ces will also be co-located with existing
EMAX facilities.
. Dr Jason Theodosiou, EMAX vice president and
general manager for Europe, is participating this
week at the Drug Discovery Technologies 2000
exhibition in Basel, Switzerland (Booth #222,
Convention Center, Basel, e-mail: jason.theodosiou
@emax.com, telephone: + 33 1 46 74 03 83).
Previously regional manager for MDL
Information Systems’ French and Southern
European operations, Dr Theodosiou holds a PhD
in Chemistry from the University of Marseilles and
an MBA from the ESCP in Paris.
Among the 68 research organizations using SciQuest.com
as their preferred or exclusive online source for scienti® c
product procurement are: The Dow Chemical Company,
DuPont Pharmaceuticals Company, Merck & Co. and
The Monsanto Company.
More about SciQuest.com
SciQuest.com, Inc., is a Web-based, interactive market-
place for scienti® c and laboratory products used by
pharmaceutical, clinical, biotechnology, chemical, indus-
trial and educational organizations worldwide. Sci
Quest.com has used its extensive industry experience to
design a marketplace that streamlines the traditionally
ine￿ cient scienti® c products supply chain. The com-
pany’s marketplace solutions allow buyers of scienti® c
products to cross-search and purchase products from
multiple suppliers with a single order, and purchase
refurbished equipment from SciQuest.com Auctions. In
March, SciQuest.com completed the acquisition of Penn-
sylvania-based EMAX Solution Partners, for the purpose
of creating an integrated e-business solution that man-
ages the entire lifecycle of scienti® c laboratory products,
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165from selection and procurement through ownership, use
and disposal. The company’s e-marketplace is distribu-
tor-neutral and can be customized and seamlessly inte-
grated with its customers’ enterprise systems, internal
inventory systems and chemical libraries.
SciQuest.com is headquartered in Research Triangle Park, NC,
USA with North American o￿ ces in Mountain View, CA,
Philadelphia, PA and Plainview, NW. For more information
about SciQuest.com please visit www.sciquest.com or call
+ 1( 919) 659-2100.
Kvaerner wins US$70 million contract for environ-
mental modi￿ cations to German re￿ nery
London, 17 April 2000: Kvaerner, the Anglo-Norwegian
engineering and construction Group, today announced
that it has won a lump-sum turnkey, engineering,
procurement and construction contract, for modi® cations
to the Holborn Europa Ra￿ nerie in Hamburg, Ger-
many. Under the US$70 million contract, which is due
for completion in the summer of 2001, Kvaerner will
modify the plant to meet stringent new European Union
directives related to the speci® cation of auto fuels.
Rene Â Westerduin, Senior Vice President of Kvaerner’s
Benelux/German operation, states: `The inherent burden
of investment to meet the new fuel speci® cations means
that the re® ner must ® nd innovative processing methods,
requiring a creative and value-oriented approach. This is
where Kvaerner’s reputation for innovative engineering
solutions provides concrete bene® ts to the re® ner.’ The
modi® cation, which isone of the ® rst of its kind in Europe
will transform diesel fuel components to the required
speci® cations by means of hydro-treatment, and follows
the recent completion by Kvaerner of another contract at
the re® nery.
The re® ning industry has continually been adjusting to
the requirement for change in fuel on the reduction of
emissions, not only from the re® neries, but also from the
fuels themselves. Kvaerner’s Benelux/German operation
has speci® c expertise in this ® eld, providing the re® ner
with a variety of options to conform to the new speci® ca-
tions, and has built up extensive expertise in the safe,
high-quality, cost-e￿ ective, fast-track execution of these
types of projects.
For further information contact: Paul Emberley, Vice-President,
Group Communications, Kvaerner PLC: + 44( 0) 20 7339 1035
or + 44( 0) 468 813090 or www.kvaerner.com.
European survey on communications in chemical
and life sciences sector launched
. Industry places priority on community and internal
communications.
. Survey indicates cynicism towards sector.
Europe’s Chemical and Life Sciences companies could
bene® t greatly from better communications practices, an
international survey has revealed. The Reputation Man-
agement European Benchmark (REMB) survey, pub-
lished today by Edelman Public Relations in Europe,
has found that although communications is an important
business function for the sector, companies still rank it
least important, giving more importance to human
resources, research and development, quality control,
safety and environment of ® nancial performance.
The Reputation Management European Benchmark
survey is the ® rst international study to analyse the
impact of corporate communications practices on cor-
porate reputation. It focuses on the ongoing practices of
sector communications and how those practices are
perceived by key stakeholders.
The survey reveals an element of criticism of and
cynicism towards the Chemical and Life Sciences sector
across Europe from both the media and other external
audiences including various opinion formers who were
interviewed as part of the Stakeholders Survey. However,
the survey also found that where the companies in the
sector communicate more actively they enjoy a better
reputation and are more positively perceived by stake-
holders. A regression analysis carried out as part of the
research demonstrates that companies can and do in¯ u-
ence how they are perceived by stakeholders. Commu-
nicating more with social organizations representatives,
journalists and authorities, isdirectly related to corporate
reputation. Despite this fact the survey found that almost
50% of journalists believe companies do not commu-
nicate with them creating an impression of a sector which
is `closed and disrespectful to the environment, to safety
or to the community’.
The survey also indicated that a majority of companies in
the sector have already developed crisis management
devices or measures. Eight-four per cent of companies
have crisis management manuals, 71% participate in
crisis communications training sessions, while 62% say
they have developed crisis communications simulations.
In this sector, companies in the UK, France and Spain
are those with most experience, except in crisis simula-
tions. Companies in Germany, Italy, Ireland and
Belgium appear at the bottom of the range. The sector
devotes, on average, 6% of its external relation’s budget
to crisis management.
One of the striking ® ndings of the report is the strong
emphasis which the companies in this sector, right across
Europe, place on both internal communications and
community relations programmes. These companies see
this as their main priority in terms of communications,
and community relations is perceived as a key task in the
day to day activities of manufacturing plants. The survey
pinpoints no national di￿ erences when companies are
asked if the concerns voiced by a plant’s neighbours be
justi® ed or not.
In this regard, companiesacross all seven countries where
the survey was conducted understand public concern for
the state of the plants. This sensitivity towards local
communities isre¯ ected in the priority, which is attached
by the sector to community relations.
The REMB survey found that on average 32% of total
spend on external relations was dedicated to advertising,
a percentage that is even higher in countries such as
Germany (40%) and Spain (39%). The second highest
budgeted activity after advertising is community rela-
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166tions representing around 15% of average budgets.
Internal communications accounted for on average
13% of the total budget, while media relations accounted
for 13% of the spend.
There were some di￿ erences between countries, e.g.
Italy, Germany and the UK place more emphasis on
media relations; Ireland places more emphasis on com-
munity relations; the UK and Belgium on lobbying;
France and Belgium on internal communications; and
France and Ireland on research and evaluation.
Over 70% of companies were found to use external
public relations services, in most cases on a project by
project basis, while 60% produce a written communica-
tions plan. These services and practices are especially
prevalent in Germany and the UK.
Commenting on the results of the study, John Mahony of
Edelman, said
`While companies in the Chemical and Life Sciences
sector rate communications as highly as some other
business functions they do not attach a high level of
importance to it. However its importance to the sector
is indicated by the fact that the top communications
managers report directly to the head of the company in
more than half of the companies and to the marketing
manager only in 5% of them. Clearly, where commu-
nications is employed internally it operates at the highest
level.
By conducting a regression analysis as part of this
research we have been able to clearly establish that good
communications can clearly improve the perception of
companies in these sectors among both media and
stakeholders. The Chemical and Life Sciences sectors
have experienced di￿ culties with regard to their image
particularly in relation to environmental and safety
issues. The ® ndings of the survey re¯ ect those di￿ culties
but also signal the very clear role which better commu-
nications practices can play in improving and enhancing
the reputation and image of companies in this sector.’
The REMBsurvey also found that the Chemical and Life
Sciences sector clearly recognises the legitimacy and
importance of lobbying. Thirty-four per cent of
companies have formal institutional/political relations
programmes. The Stakeholders survey indicated that
the sector can assist in identifying important issues but
it was less clear as to the legitimacy of lobbying in the
sector.
`The role of the lobbyist is one which has been under
review particularly by institutions and the media in
many European countries. Clearly, this research high-
lights again the element of cynicism towards lobbying.’
Mahony added.
Commenting on the results of the survey, Mrs Nuria
Salo, Director of Masters in Communication to Organ-
isation, Bosch i Gimpera Foundation said; `Following two
years of work in conjunction with the largest European
Companies of the Chemical and Life Sciences sectors,
universities, NGO’s journalists, and Public Administra-
tions from seven countries, the REMB study has con-
® rmed our view that external communications can
in¯ uence and condition the perception which people
have on companies in this sector.’
The survey was conducted among companies in the
Chemical and Life Sciences sectors in seven countries
(Belgium, Italy, Spain, Ireland, France, Germany and
the UK). Key stakeholders in ® ve of these seven countries
were also interviewed as part of the survey. These
included journalists, authorities with environmental or
safety responsibilities, representatives of environmental
groups and representatives of scienti® c institutions. The
study has been designed and developed by the University
of Barcelona, Bosch i Gimpera Foundation and Edelman
PR Worldwide Europe.
For further information please contact: Simon Scott, Director
Media Relations, Edelman Public Relations Worldwide Tel:
( 0) 2 17344 1253; or Ian O’Doherty, Edelman Public Relations
Worldwide Tel: ( 0) 2 71344 1554
Schroder Ventures raises £3 billion European
Fund for investment in healthcare and chemicals
London, 11 May 2000: Schroder Ventures announces the
raising of its second European priviate equity fund,
Schroder Ventures European Fund II (SVEF2) which
will invest heavily in the healthcare and chemicals
buyouts. Just 3 months after its formal launch, Schroder
Ventures hasreceived applications from investors for over
£ 3 billion, the maximum size set for the fund.
The record speed with which this fund has been rasied
re¯ ects the outstanding performance of its predecessor,
the Schroder Ventures European Fund (SVEF1).
SVEF1, which was raised in 1997, was Europe’s ® rst
billion dollar private equity fund. It is now fully com-
mitted to 21 investments, all companies head-quartered
in Europe. Investments include Leica Microsystems
(world leading microscopy business), Sirona Dental
Systems (world leading dental equipment manufacturer),
Mueller & Weygandt (dental consumerables manufac-
turer), Betts (pharmaceutical packaging business) and
Expand Sante Â (contract sales organization for pharma-
ceutical sector) ± all businesses active in the healthcare
sector. SVEF1 has already returned cash to investors
equivalent to 134% of the fund within 3 years of the
fund’s launch.
The investment strategy of the new fund, SVEF2, will
follow that of its predecessor, SVEF1. The fund will make
both leveraged acquisitions and growth capital invest-
ments with a particular focus on the new economy.
Seventeen of the ® rst fund’s 21 investments have been
in the healthcare and technology sectors.
The new fund has been raised from a broad spectrum of
investors, 78% of which (by value) are existing investors
with Schroder Ventures. Just over half (53%) of the
funding came from European investors, with 41% com-
ing from North America and 6% from the Far East.
Since the mid-1990s, Schroder Ventures has adopted a
pan-European approach to investment with regional
funds and an integrated European team, operating out
of four o￿ ces in London, Frankfurt, Milan and Paris.
The professional team numbers over 50, with 19 partners,
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167who on average have been with Schroder Ventures 9
years.
Schroder Ventures’ funds have been investing in Eur-
opean healthcare businesses for 15 years. Notable prior
investments include Chiroscience, Shire Pharmaceuticals
and Micromass.
Schroder Ventures does not intend to accept any new
applications for commitments in the fund.
For futher information, contact: Schroder Ventures, Charles
Sherwood, Partner, London. Tel: + 44 ( 0) 20 7632 1032; or
Amanda Shaw, Marketing Manager, Tel: + 44 ( 0) 20 7632
1007/44 ( 0) 7979 706768.
Announcement
New CAMAG catalogue: Planar Chromatography
2000 – modern thin-layer chromatography
Planar Chromatography is a modern separation tech-
nique which is accepted by regulatory agencies and
analysts as an extremely ¯ exible, reliable and cost-
e￿ ective method. It issuccessfully used in pharmaceutical
industry, food analysis, natural products/herbals and
many other ® elds of application.
Besides information on CAMAG products and services
the catalogue includes a brief guide to the operating
procedure of Planar Chromatography.
The catalogue contents and ancillary information on
CAMAG services can also be accessed in the Internet
under www.camag.ch
For further information please contact: Delphine Stoå el, Sales &
Marketing Administration, CAMAG, CH-4132 Muttenz/
Switzerland. Tel: + 41 61-467 34 34; Fax: + 41 61-461 07
02; e-mail: info@camag.ch
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